This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Divine Skin (DSKX) Secures $1.73M In New Equity Growth Capital To Fund Its Rapidly Growing Biotech Product Line

Stocks in this article: DSKX

MIAMI BEACH, Fla., Oct. 5, 2011 /PRNewswire/ -- Divine Skin, Inc. (OTC Bulletin Board: DSKX) announced the completion of a $1.73 million equity capital raise. Littlebanc Advisors, LLC, acted as the sole placement agent and financial advisor for Divine Skin. The deal was funded by both private and institutional investors. The growing biotech developer will deploy the new capital to fill orders for its expanding pipeline of distributors in Europe, Mexico, and Japan, as well as in the United States.

"We chose Littlebanc because of its successful track record of providing unstructured equity growth capital to early-stage companies," said Daniel Khesin, CEO of Divine Skin. "We view Littlebanc's involvement as an endorsement of what we are achieving."

"Divine Skin's high-quality and proprietary products have allowed the company to achieve impressive revenue growth since inception," said Michael Margolies, CEO of Littlebanc Advisors. "This round of financing will allow Divine Skin to continue acquiring market share with their innovative products. We are very pleased to be working with another high-growth Florida company."

Divine Skin's recent achievements include:

  • A record-setting $2.3 million in quarterly revenue for Q2 2011.
  • The release of the world's first topical hair-growth treatment based on the breakthrough peptide astressin-B.  
  • The introduction of the new compound Nanoxidil, designed to surpass minoxidil for efficacy and tolerability, which will facilitate new international distribution agreements.

About Divine Skin

Divine Skin Inc. leads in the development of biotechnology for topical, nutritional, and pharmaceutical therapies. It markets worldwide through online and specialty retailers, cosmetics wholesalers, salons, and medical offices. The fast-growing company went public in 2009 ( www.dskx.biz).

DS Laboratories, its flagship brand, offers high-performance topical solutions to restore growth and radiance to hair, suppress dandruff and unwanted hair, control acne, improve hygiene, and reduce cellulite and wrinkles. Bioavailability is enhanced through encapsulation ( www.dslaboratories.com).

The Sigma Skin brand sells through upscale retailers like Neiman Marcus in the United States and Harvey Nichols in the United Kingdom. The topical products address hair loss and other signs of aging ( www.sigmaskin.com).

Polaris Research Laboratories makes high-potency minoxidil-based hair-growth formulas ( www.polarisresearchlabs.com).

The Pure Guild offers purity with performance: Botanical compounds proven effective in clinical trials are extracted without industrial solvents or damaging heat and are sold through premium retailers ( www.thepureguild.com).

NutraOrigin blends nutritional supplements that address the health concerns expressed by consumers, including fatigue, headache, obesity, mobility, menopause, erectile dysfunction, and others. In clinical trials for the US government, its Omega line proved to enhance mental function ( www.nutraorigin.com).

About Littlebanc Advisors

Littlebanc Advisors, a merchant and investment banking firm based in Boca Raton, Florida, specializes in funding high-quality small to mid-market growth companies. Littlebanc focuses on unstructured deals sold to fundamental growth-stock investment funds. With long-established Wall Street relationships, Littlebanc matches client companies with partner-minded investors. For more information, please visit www.littlebanc.com.

Contact: Abner SilvaInvestor Relations Divine Skin Inc.1.407.342.4112 investors@divineskin.com

SOURCE Divine Skin, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs